Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Tripeptides – e.g. – tripeptide thyroliberin – etc.
Patent
1995-06-07
1999-06-01
Knode, Marian C.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Tripeptides, e.g., tripeptide thyroliberin , etc.
530330, 530332, 530333, 514 18, C07K 508, C07K 5023, A61K 3800, A61K 3806
Patent
active
059089199
ABSTRACT:
Compounds of the formula ##STR1## or of the formula ##STR2## or the amides, esters or salts thereof, wherein: S.sup.x is S.dbd.O, O.dbd.S.dbd.O, S.dbd.NH, HN.dbd.S.dbd.O, Se.dbd.O, O.dbd.Se.dbd.O, Se.dbd.NH, HN.dbd.Se.dbd.O, S.sup.+ R.sup.3 wherein R.sup.3 is alkyl (1-6C) or O--C.dbd.O or HN--C.dbd.O;
REFERENCES:
patent: 4851388 (1989-07-01), Bright
patent: 4963263 (1990-10-01), Kauvar
patent: 5133866 (1992-07-01), Kauvar
patent: 5204241 (1993-04-01), Pero
patent: 5430045 (1995-07-01), Goldberg et al.
patent: 5545621 (1996-08-01), Kauvar et al.
patent: 5556942 (1996-09-01), Kauvar et al.
patent: 5648506 (1997-07-01), Desai et al.
Adang, et al., "The Glutathione-Binding Site in Glutathione S-Transferases, Investigation of the cysteinyl, glycyl and y-glutamyl domains" Biochem. J. 269:47-54 (1990).
Borch et al., "Synthesis and Antitumor Properties of Activated Cyclophosphamide Analogues," J Med Chem (1991) 34:3044-3052.
Borch et al., "Synthesis, Activation and Cytotoxicity of Aldophosphamide Analogues," J. Med Chem (1991) 34:3052-3058.
Borch et al., "In Situ Preparation and Fate of cis-4-Hydroxycyclophosphamide and Aldophosphamid: .sup.1 H and .sup.31 P NMR Evidence for Equilibration of cis- and trans-4-Hydroxycyclophosphamide with Aldophosphamide and Its Hydrate in Aqueous Solution," J Med Chem (1984) 27:490-494.
Borch et al., "The Mechanism of Activation of 4-Hydroxycyclophosphamide," J Med Chem (1987) 30:427-431.
Campling, et al. "Do glutathione and related enzymes play a role in drug resistance in small cell lung Cancer cell lines?" Br. J. Cancer 68:327-335 (1993).
Castro, et al., "Differences Among Human Tumor Cells in the Expression of Glutathione Transferases and Other Glutathione-Linked Enzymes" Carcinogenesis Oxford University Press, 1569-1576 (1990).
Chatterjee, et al., "Idiotypic antibody immunotherapy of cancer" Cancer Immunol. Immunotherap. 38:75-82 (1994).
Dermer "Another Anniversary for the War on Cancer" Biotechnology 12:320 (1994).
Fenselau, C. and P.B.W. Smith, "High-Performance tandem mass spectrometry in metabolism studies", Xenobiotica 22(9/10):1207-1219 (1992).
Flatgaard et al., "Isozyme specificity of novel glutathione-S-transferase inhibitors" Cancer Res. 33:63-70 (1993).
Held, et al., "Effect of Dimethyl Fumarate on the Radiation Sensitivity of Mammalian Cells in Vitro" Radiation Research 115: 495-502 (1988).
Houghton Mifflin Company Webster's II New Riverside University Dictionary, 849 (1988).
Kauvar, et al., "Paralog Chromatography" Biotechniques 8:204-209 (1990).
Ketterer, B. et al., "Glutathione Conjugation : Mechanisms and Biological Significance", Sies, H., et al., eds., (1988) Academic Press, London, pp. 74-137.
Lyttle, M.H. et al., "Glutathione-S-Transferase Activates Novel Alkylating Agents" J Med Chem 37(10):1501-1507 (1994).
Mannervik, B. et al., "Glutathione Transferases--Structure and Catalytic Activity" CRC Crt Rev Biochemistry (1988) 23:283-355.
Mannervik, et al. "Identification of Three Classes of Cytosolic Glutathione Transferase Common to Several Mammalian Species: Correlation Between Structural Data and Enzymatic Properties" Proc. Natl. Acad. Sci. USA, 82:7202-7206 (1985).
Merck Manual, Fifteenth Edition, Merck & Co., Rahway, NJ (1987) pp. 1120-1121.
Morris, D., "Synthesis of the .alpha.- and .gamma.-Isomers of Glutamylcystinylvaline", Biochem J. (1960) 76:349-353.
O'Dwyer et al., "Depletion of Glutathione in Normal and Malignant Human Cells In Vivo by Buthionine Sulfoximine: Clinical and Biochemical Results" J NCI 84:264-267 (1992).
O'Dwyer et al., "Phase I Study of Thiotepa in Combination with the Glutathione Transferase Inhibitor Ethacrynic Acid" Cancer Res. 51:6059-.
Principato, G.B., et al., "Effects of Some S-Blocked Glutathione Derivatives on the Prevalent Glyoxalase II (a Form) of Rat Liver, Enzyme" Biochem J. (1989) 41:175-180.
Puchalski, R.B. et al., "Expression of Recombinant Glutathione S-Transferase .pi., Ya, or Yb.sub.1 Confers Resistance to Alkylating Agents" Proc Natl Acad Sci USA (1990) 87:2443-2447.
Reinemar, P., et al., "Three-dimensional Structure of Class .pi. Glutathione S-Transferase from Human Placenta in Complex with S-Hexylglutathione at 2.8 A Resolution"; J Mol Biol (1992) 213:214-226.
Ricci, et al. "Detection of Glutathione Transferase Activity on Polyacrylamide Gels" Analytical Biochemistry 143, 226-230 (1984).
Ripple, et al., "Characteristics of the Glutathione/Glutathione-S-Transferase Detoxification System in Melphalan Resistant Human Prostate Cancer Cells" J. Urology 150:209-214 (1993).
Satou, Patent Abstracts of Japan; JP-A-60-199-384, vol. 10, No. 56; Glutathione S-transferase.
Schisselbauer, J.C., et al., "Characterization of Glutathione S-Transferase Expression in Lymphocytes from Chronic Lymphocytic Leukemia Patients"; Cancer Res (1990) 50:3562-2568.
Sharer et al., "Formation, stability and rearrangements of the gluthathione conjugates of butadiene monoxide; evidence for the formation of stable surfurane intermediates", Chem. Res. Toxicol. (1991), 4(4):430-6 CODEN: CRTOEC; ISSN:0893-228X, 1991, pp. 434-435.
Sheh, et al. "Synthesis of Cyclic Peptide Homologs of Glutathione as Potential Antitumor Agents" Int. J. Peptide protein Res. 35:55-62 (1990).
Smith, et al. "Denitrosation of 1,3-Bis(2-chloroethyl)-1-nitrosourea by Class Mu glutathione Transferases and Its Role in Cellular Resistance in Rat Brain Tumor Cells" Cancer Research 49:2621-2625 (1989).
Takeo, et al. "Binding Constants of Dextrans and Isomaltose Oligosaccharides to Dextran-Specific Myeloma Proteins Determined by Affinity Electrophoresis" J. Immunol.. 121:2305-2310 (1978).
Tew, et al. "Ethacrynic Acid and Piriprost as Engancers of Cytotoxicity in Drug Resistant and Sensitive Cell Lines" Cancer Research 48:3622-3625 (1988).
van Bladeren, et al., "The Inhibition of Glutathione S-Transferases: Mechanisms, Toxic Consequences and Therapeutic Benefits" Pharmac. Ther. 51:35-46 (1991).
Vos. et al. "Differential Induction of Rat Hepatic Glutathion S-Transferase Isoenzymes by Hexachlorobenzene and Benzyl Isothiocyanate" Biochemical Pharmacology No.37(6):1077-1082 (1988).
Waxman "Gluthathione S-Transferases Role in Alkylating Agent Resistance and Possible target for Modulation Chemotherapy--A Review" Cancer Research 50:6449-6454 (1990).
Wiencke et al. "Human Glutathione S-Transferase Deficiency as a Market of Susceptibility to Expoxide-Induced Cytogenetic Damage" Cancer Research 50:1585-1590 (1990).
Ciaccio P.J. et al. "Modulation of Detoxification Gene Expression in Human Colon HT129 Cells by Glutathione-S-Transferase Inhibitors" Molecular Pharmacology 48:639-647 (1995).
Annual Meeting of the Canadian Society for Clinical Investigation and the Royal College of Physicians and Surgeons of Canda, Montreal, Quebec, Canada, Sep. 13-17, 1995, "Clinical and Investigative Medicine," vol. 18 (4 Suppl.) (1995), Cournoyer D. et al.
Morgan A. S. et al. "Isozyme-specific Glutathione S-Transferase Inhibitors Potentiate Drug Sensitivity in Cultured Human Tumor Cell Lines," Cancer Chemother. Pharmacol. 37:363-370 (1996).
Kauvar Lawrence M.
Lyttle Matthew H.
Satyam Apparao
Knode Marian C.
Lee Datquan
Murashige Kate H.
Terrapin Technologies
LandOfFree
Urethane mediated, GST specific molecular release systems does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Urethane mediated, GST specific molecular release systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urethane mediated, GST specific molecular release systems will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-955641